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Abstract
Purpose To investigate whether follicular fluid lipid-soluble
micronutrients are associated with embryo morphology
parameters during IVF.
Methods Follicle fluid and oocytes were obtained prospec-
tively from 81 women. Embryo morphology parameters
were used as surrogate markers of oocyte health. HDL
lipids and lipid-soluble micronutrients were analyzed by
high-pressure liquid chromatography. Non-parametric bi-
variate analysis and multivariable ordinal logistic regression
models were employed to examine associations between
biochemical and embryo morphology parameters.
Results Follicular fluid HDL cholesterol (r=−0.47, p<0.01),
α-tocopherol (r=−0.41, p<0.01),δ-tocopherol (r=−0.38, p<
0.05) and β-cryptoxanthine (r=−0.42, p<0.01) are negative-
ly correlated with embryo fragmentation. Ordinal logistic
regression models indicate that a 0.1 μmol/L increase in β-
cryptoxanthine, adjusted for γ-tocopherol, is associated with
a 75% decrease in the cumulative odds of higher embryo
fragmentation (p=0.010).
Conclusion Follicular fluid HDL micronutrients may play
an important role in the development of the human oocyte
as evident by embryo fragmentation during IVF.
Keywords Highdensitylipoprotein.Tocopherols.
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Introduction
Human ovarian follicular fluid (FF) contains high density
lipoprotein (HDL) as the predominant lipoprotein with only
traces of other lipoproteins [1, 2]. The importance of HDL
in mammalian female reproduction is demonstrated by
scavenger receptor class B group I, knockout (SR-BI KO)
female mouse-generated embryos which arrest due to
aberrant HDL metabolism [3–6]. In clinical studies, we
have demonstrated negative correlations between FF HDL
cholesterol and ApoAI levels with embryo fragmentation
during in vitro fertilization (IVF) [7, 8]. These observations
prompted us to further examine particular FF HDL
components and examine their association with embryo
morphology parameters during IVF. Since HDL is the
major FF lipoprotein, we hypothesized that HDL is also the
major carrier of lipid-soluble vitamins and micronutrients in
FF. Our objective was to measure the lipid-soluble vitamin
and micronutrient content of FF and to examine their
associations with embryo morphology parameters in wom-
en undergoing IVF.
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Capsule Follicular fluid lipid-soluble vitamins and micronutrients are
correlated with HDL and may explain the observed association
between HDL and embryo morphology parameters during IVF.
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Subjects and samples
Eighty-seven female patients undergoing IVF treatment at
the UCSF Center for Reproductive Health were recruited
into this study with full informed consent. The study
protocol and consenting process were approved by the
UCSF Committee on Human Research. Table 1 describes
the demographic characteristics of the study participants.
Participants underwent gonadotropin-induced ovarian stim-
ulation per clinic protocols as described previously [7]. FF
from an individual mature 18–20 mm follicle was aspirated
and processed immediately via centrifugation at 700 g for
10 min at room temperature and the straw-colored FF
supernatant was cryopreserved in 1.8 cc aliquots at −80°C.
Individual FF analytes were tracked to corresponding
oocytes and embryos to examine the association between
analyte levels and embryo outcomes.
IVF protocol
Intracytoplasmic sperm injection (ICSI) was performed in
most cases (∼87%) based on abnormal sperm parameters
from prior semen analyses. All metaphase-II oocytes were
fertilized on the day of oocyte collection with a previously-
cryopreserved sperm specimen from the male partner or
sperm donor. Zygotes were identified approximately 16–
18 h following insemination, by the appearance of two
pronuclei (2PN). All embryos were cultured individually in
5% CO2 with filtered room air in 25 uL of G1™ culture
media (Vitrolife, Inc. Englewood, CO USA) with 10%
synthetic serum substitute (SSS) and Ovoil
TM (Vitrolife
Inc.) paraffin oil overlay. Embryo morphologic indices
included individual embryo cell number (ECN) and individ-
ual embryo fragmentation score (EFS), each assessed on the
day of embryo transfer. Experienced embryologists making
embryo morphology assessments were blinded to any
biochemical results and the laboratory technicians were
blinded to clinical outcome data. EFS was defined as: grade
1, 0% fragmentation; grade 2, 1–10% fragmentation; grade
3, 11–25% fragmentation, grade 4, 26–50% fragmentation;
and grade 5, 51% or greater fragmentation.
Laboratory methods
FF HDL fractions were prepared by selective precipitation
methods as previously described [7] since ultracentrifuga-
tion is known to alter lipoprotein structure [9]. Vitamin A,
vitamin E (α,γ and δ tocopherol) and carotenoids (β-
carotene, β-cryptoxanthin, lycopene, lutein and zeaxanthin)
were measured simultaneously by HPLC [10]. Lutein and
zeaxanthin were quantified together as a single peak and
reported as a total lutein/zeaxanthin. Apolipoprotein-AI
(ApoAI), Apo B-100, cholesterol, phospholipids and
triglycerides were measured using diagnostic reagent kits
from Wako Diagnostics Inc. (Richmond, VA, USA) adapted
to the Cobas Fara II automated chemistry analyzer
(Hoffmann–La Roche Banal, Switzerland). All analyses
were performed in duplicate.
Data analysis
Non-parametric statistical tests and models were employed
using SAS 9.1.3 (SAS Institute, Inc. Cary, NC, USA).
Statistical significance was defined as P<0.05 for a two-
tailed test. No correction for potential inflation of type-1
error due to the conduct of multiple statistical tests was
incorporated. Spearman rank correlation coefficients were
used to assess associations among and between FF HDL
components and embryo morphologic indices. Using a
stepwise procedure and a model building algorithm, to
accommodate potential interactions and confounders, indi-
vidual multivariable ordinal logistic regression models were
Demographic covariates Mean SD Median Min. Max. Treatment covariates n %
Age (years) 36.2 5.9 37.7 20.9 44.0 Prior IVF cycle
b 39 50.0
BMI (kg/m
2)
a 23.5 3.4 22.6 18.1 35.4 Diagnosis
c
Patient ethnicity n % Unexplained 20 25.3
Caucasian 45 55.6 –– – Male factor 23 29.1
Asian (East Asia) 22 27.2 –– – DOR 15 19.0
Unknown 9 11.1 –– – Donor oocyte 10 12.7
Hispanic 2 2.5 –– – Tubal Factor 4 5.1
African American 1 1.2 –– – Endometriosis 4 5.1
Asian (Indian) 2 2.5 –– – Recurrent SAB 2 2.5
Anovulation 1 1.3
ICSI 66 81.5
Table 1 Characteristics of
study participants by demo-
graphic, treatment, and outcome
(n=81)
an=5 missing values;
bn=3
missing values;
cn=2 missing
values; BMI body mass index;
IVF in vitro fertilization; DOR
diminished ovarian reserve; SAB
spontaneous abortion; ICSI
intra-cytoplasmic sperm
injection
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3–5; n=13/ 15/ 11) or ECN limited to day-three transfers
(4–5 cells/ 6–7 cells/ 8–11 cells; n=4/ 10/ 16). Model fit
and the proportional odds assumption were evaluated
throughout multivariable modeling, and missing values
were imputed using an EM algorithm.
Results
Oocytes were retrieved from the sampled ovarian follicle in
83 of the 87 study participants undergoing IVF. FF volume
collected from two participants was insufficient for any
analysis therefore 81 participants with harvested oocytes
and sufficient FF volume for analysis comprised the final
study sample. Among all study oocytes 83.9% (n=68) were
arrested in Metaphase-II and 66.2% (n=45) of these mature
oocytes were normally fertilized (2PN) by either conven-
tional IVF or intracytoplasmic sperm injection (ICSI).
Sample size varied for certain analytes due to the limited
volume of FF collected during this pilot study. The
complete demographic, treatment and outcome variables
for the study sample are described in Table 1. Table 2
presents the distributions of the absolute levels of all study
analytes in FF as well as the correlation of each variable
with FF-HDL cholesterol, EFS and ECN adjusted for day
of transfer.
Except for β-carotene and γ-tocopherol, all FF fat-
soluble vitamins and micronutrients are significantly posi-
tively correlated with FF HDL cholesterol concentration.
With this expansion of the dataset from our prior report (8),
FF total HDL cholesterol remains negatively correlated
with EFS (r=−0.47, P=0.003). FF concentrations of α-
tocopherol (r=−0.41, P=0.009), δ-tocopherol (r=−0.38, P=
0.017) and β-cryptoxanthine (r=−0.42, P=0.008) are also
negatively correlated with EFS. While other FF micro-
nutrients also correlate negatively with EFS, these do not
approach statistical significance (P>0.10). No meaningful
correlations are detected between ECN, adjusted for day of
embryo transfer, and FF analytes (P>0.15).
Table 3 presents the ordinal logistic regression model for
EFS in which a 0.1 µmol/L increase in FF β-cryptoxanthin
concentration is associated with a statistically significant
(P=0.010) decrease of 75% in the cumulative odds (odds
ratio = 0.25) for an increased EFS, conditional on FF γ-
tocopherol. FF γ-tocopherol is itself significantly associat-
ed with a 66% decrease in the cumulative odds (odds
ratio = 0.34) for an increased EFS (P=0.035) for each one
1.0 µmol/L increase in concentration. There are no
significant predictors of ECN.
Measured analytes Units n Median IQR rHDLC n rEFS rECN
a
HDLC mmol/L 81 0.57 0.34 – 39 −0.47** −0.02
ApoAI g/L 81 1.05 0.22 0.25
* 39 −0.25 0.13
HDL-PL mmol/L 80 0.78 0.15 0.55** 39 −0.18 0.03
HDL-TG mmol/L 79 0.07 0.06 −0.01 38 0.07 −0.13
Retinol umol/L 80 0.01 0.03 0.47** 39 −0.08 −0.01
α-tocopherol umol/L 80 5.50 3.31 0.66** 39 −0.41** 0.09
γ-tocopherol umol/L 67 1.00 0.85 0.23 31 −0.34 −0.01
δ-tocopherol umol/L 74 0.34 0.58 0.40** 38 −0.38* −0.04
β-carotene umol/L 80 0.11 0.14 0.16 39 −0.22 0.07
β-cryptoxanthin umol/L 80 0.07 0.07 0.37** 39 −0.42** 0.08
Lycopene umol/L 80 0.21 0.14 0.52** 39 −0.24 −0.16
Lutein and zeaxanthin umol/L 80 0.12 0.07 0.42** 39 −0.26 0.18
Table 2 Distributions of follic-
ular fluid HDL components and
correlations with HDL choles-
terol, embryo fragmentation
score (EFS) and embryo cell
number (ECN)
aAdjusted for day of embryo
transfer;
*p<0.05;
**p<0.01 (2-
tailed). r (Spearman rank corre-
lation coefficient with HDLC,
EFS or ECN); IQR interquartile
range; ApoAI (apolipoprotein
AI); HDLC (high density lipo-
protein cholesterol); PL (phos-
pholipids); TG (triglycerides)
Table 3 Ordinal logistic regression of higher embryo fragmentation score (EFS) on follicular fluid β-cryptoxanthine and γ-tocopherol
concentrations (n=39)
β 95% CI Lo 95% CI Hi P-value unit Δ OR
Intercept 2 1.29 −0.32 2.90 0.117 ––
Intercept 1 3.44 1.45 5.43 0.001 ––
β-cryptoxanthine −1.37 −2.41 −3.34 0.010 0.1 μmol/L 0.25
γ-tocopherol
a −1.07 −2.06 −0.07 0.035 1.0 μmol/L 0.34
an=8 missing values imputed employing an EM algorithm. β, slope; CI confidence interval; OR odds ratio; Δ, unit of change
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In summary, we extend our initial observations [7, 8] with
additional evidence in support of a role for the HDL par-
ticle in the developmental potential of the human oocyte
during early embryogenesis. We have now demonstrated
that multiple components of FF HDL particles including
cholesterol, ApoAI, and the micronutrients, ß-cryptoxanthine
and γ-tocopherol, represent unique clinical predictors of
embryo fragmentation during IVF. From these results it is
unclear whether the HDL particles themselves or co-linear
HDL particle components such as ß-crytoxanthin and α-
tocopherol are responsible for the protective effect against
embryo fragmentation. It is clear that the strong correlations
between HDL and lipophilic micronutrient levels in FF
prompt all future studies to consider adjusting for associated
covariates during statistical analyses. While previous studies
have not demonstrated significant clinical effects associated
with carotenoids, retinoids, or tocopherols, it is not clear that
either study analyzed the relationship with embryo morphol-
ogy parameters [12, 13]. Consistent with Schweigert et al.
we observe similarly reduced levels of micronutrients in FF
compared to plasma [13]. Our observations suggest that
numerous lipophilic components of HDL particles including
micronutrients may be influencing the membrane and cyto-
plasmic properties of the oocyte with downstream effects on
embryo fragmentation occurring during in vitro cytokinesis.
There are several notable limitations to this study: (1) we
cannot make any conclusions regarding a role for sperm
factors eventhoughweconsideredtotal motilesperm count in
our multivariate analyses; and (2) these findings are simply
associations and do not necessarily imply causal effect. We
acknowledge that more detailed human and mammalian
studies need to be performed in order to assess causality.
To what extent the constitution of the FF HDL particle is
a reflection of intra-follicular metabolic processing versus
extra-follicular modeling is not known. Our understand of
FF HDL metabolism during folliculogenesis and oocyte
development is limited and further complicated by the
multiple proteins and lipids that interact with and contribute
to the biological roles of HDL particles [8]. Given the
relative predominant existence of HDL particles in FF
during folliculogenesis, it remains to be determined if these
lipophilic micronutrients are influencing oocyte develop-
ment independent of intra-follicular cholesterol and phos-
pholipid transport mechanisms [8]. Our findings raise
interesting questions regarding the biological mechanisms
that are directing apparent effects of HDL-associated
micronutrients on oocyte development and competence.
Furthermore, the negative correlations between multiple FF
HDL components and embryo fragmentation provide
reasons to consider HDL particle composition as a useful
biomarker of embryo fragmentation during IVF.
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